What is the recommended protocol for Platelet-Rich Plasma (PRP) activation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Platelet-Rich Plasma (PRP) Activation Protocol

The recommended protocol for PRP activation should include either calcium chloride, autologous thrombin, a combination of both, or collagen type I as activating agents, with the choice depending on the specific clinical application and desired release kinetics of growth factors. 1, 2

Blood Collection and Initial Processing

  • Collect blood using plastic tubes (not glass) to avoid contact activation 1
  • Use appropriate anticoagulants: trisodium citrate (0.109M), ACD, or CPD; NEVER use EDTA as it causes platelet swelling and premature activation 1
  • Process blood at room temperature as soon as possible, preferably within 1 hour of collection 1
  • For PRP preparation, centrifuge at low force (170-200g) for 10 minutes at room temperature for optimal platelet yield 1

Centrifugation Protocol

  • For standard PRP: Use a single low-speed centrifugation (170-200g for 10 minutes) 1
  • For platelet-concentrated plasma (PCP): After initial PRP preparation, perform a second centrifugation at >2300g, remove 90% of supernatant plasma, and resuspend platelets 3
  • Centrifugation should occur at controlled room temperature to avoid precipitation and cold activation 1

PRP Activation Methods

Common Activation Options:

  1. Calcium Chloride (10%)

    • Produces progressive release of growth factors over 24 hours
    • Forms a clot within 15 minutes
    • Provides sustained release of VEGF, PDGF-AB, and TGF-β1 2
  2. Autologous Thrombin (10%)

    • Causes immediate release of growth factors that remains stable over time
    • Forms a clot within 15 minutes
    • Suitable when immediate availability of growth factors is desired 2
  3. Calcium Chloride + Thrombin Mixture (10%)

    • Combines effects of both activators
    • Forms a clot within 15 minutes
    • Provides immediate and stable release of PDGF and TGF-β1 2
  4. Collagen Type I (10%)

    • Does not form a clot
    • Produces lower overall growth factor release
    • May be preferred when clot formation is undesirable 2
  5. Temperature-Controlled Activation

    • Novel method without additives
    • Prepare PRP under hypothermic conditions (4°C)
    • Activate by rewarming to 37°C
    • Creates natural fiber scaffolding with slower growth factor release 4

Timing Considerations

  • Freshly prepared PRP should be used within 4 hours for optimal results 1
  • If activation is performed, the timing depends on the specific application:
    • For immediate growth factor release: use thrombin or calcium chloride/thrombin mixture 2
    • For gradual release over time: use calcium chloride activation 2

Clinical Application Considerations

  • In some applications, collagen-rich tissues may activate PRP naturally, eliminating the need for pre-application activation 1
  • The activation method significantly affects both the physical form of PRP and the release kinetics of growth factors 2
  • Document the activation procedure used, as this is considered an appropriate practice by expert consensus 1

Important Caveats and Pitfalls

  • PRP preparations vary widely in content, purity, and biological properties, which impacts clinical efficacy 1
  • The concentration of platelets should be at least 2-3 times above baseline for therapeutic effect 5
  • Avoid storing PRP at 4°C as cold activation might occur prematurely 1
  • If using frozen PRP, thaw samples in a water bath at 37°C for 2-5 minutes (depending on volume) until completely thawed 1
  • The choice of activation method should align with the desired release profile of growth factors for the specific clinical application 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.